Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Life360, Inc.LIF · Entity 1972 | Director | October 06, 2026 | October 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Life360, Inc.
Report date October 06, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 1,010,303 |
Last balance in matching sequence
After 2026-10-06 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-06 · Exercise / conversion · Acquired 50,000 · Balance 1,060,303 F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Row 2 · 2026-10-06 · Sale · Disposed 48,608 · Balance 1,011,695 F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.137 to $42.135, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3. F2: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Row 3 · 2026-10-06 · Sale · Disposed 1,392 · Balance 1,010,303 F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.145 to $42.74, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4. F2: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.53 · Expires 2028-07-16 | Direct | 145,565 |
Reported balance
After 2026-10-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-06 · Exercise / conversion · Disposed 50,000 · Balance 145,565 F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F5: The stock option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
F2: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.137 to $42.135, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.145 to $42.74, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
F5: The stock option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 8, 2026 22:09 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.53 | $0.00 |
DisclosureSEC source: 0001581760-26-000169 · wk-form4_1791497381.xml · derivative · entry 4 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,565 Underlying: Common stock · 50,000 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F5 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| October 06, 2026 Filed Oct 8, 2026 22:09 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 1,392 | $42.36 | $58,965.12 |
DisclosureSEC source: 0001581760-26-000169 · wk-form4_1791497381.xml · nonDerivative · entry 3 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,010,303 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.145 to $42.74, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4. F2 · balance_after: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| October 06, 2026 Filed Oct 8, 2026 22:09 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 48,608 | $41.41 | $2,012,857.28 |
DisclosureSEC source: 0001581760-26-000169 · wk-form4_1791497381.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,011,695 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.137 to $42.135, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3. F2 · balance_after: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| October 06, 2026 Filed Oct 8, 2026 22:09 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionCommon stock | 50,000 | $2.53 | $126,500.00 |
DisclosureSEC source: 0001581760-26-000169 · wk-form4_1791497381.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,060,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:48 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.53 | $0.00 |
DisclosureSEC source: 0001581760-26-000165 · wk-form4_1790196483.xml · derivative · entry 4 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 195,565 Underlying: Common stock · 50,000 shares Expires 2028-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F5 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:48 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 18,725 | $41.16 | $770,721.00 |
DisclosureSEC source: 0001581760-26-000165 · wk-form4_1790196483.xml · nonDerivative · entry 3 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,010,303 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.047 to $41.340, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4. F2 · balance_after: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:48 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 31,275 | $40.72 | $1,273,518.00 |
DisclosureSEC source: 0001581760-26-000165 · wk-form4_1790196483.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,029,028 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.04 to $41.02, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3. F2 · balance_after: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:48 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionCommon stock | 50,000 | $2.53 | $126,500.00 |
DisclosureSEC source: 0001581760-26-000165 · wk-form4_1790196483.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,060,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:52 UTC | Life360, Inc. LIF · Entity 1972 | GrantCommon stock | 4,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-26-000096 · wk-form4_1780437169.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,010,303 F1 · kind: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. F2 · balance_after: Includes 5,134 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionStock Option (right to buy) · Derivative | 15,972 | $0.00 Strike: $13.35 | $0.00 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 6 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 15,972 shares Expires 2027-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionStock Option (right to buy) · Derivative | 3,170 | $0.00 Strike: $8.19 | $0.00 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 5 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,729 Underlying: Common stock · 3,170 shares Expires 2028-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionStock Option (right to buy) · Derivative | 125,391 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 4 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 125,391 shares Expires 2027-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionCommon stock | 15,972 | $13.35 | $213,226.20 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 3 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,005,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionCommon stock | 3,170 | $8.19 | $25,962.30 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 989,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC | Life360, Inc. LIF · Entity 1972 | Exercise / conversionCommon stock | 125,391 | $2.15 | $269,590.65 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 986,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon Stock | 722 | $64.49 | $46,561.78 |
DisclosureSEC source: 0000905148-25-004432 · form4.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon Stock | 1,165 | $63.63 | $74,128.95 |
DisclosureSEC source: 0000905148-25-004432 · form4.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 722 F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 02:41 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon Stock | 52,111 | $76.90 | $4,007,335.90 |
DisclosureSEC source: 0000905148-25-004206 · form4.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 861,315 F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.42 to $77.37, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes 2,714 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 02:41 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon Stock | 47,889 | $75.95 | $3,637,169.55 |
DisclosureSEC source: 0000905148-25-004206 · form4.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 913,426 F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $75.42 to $76.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes 2,714 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| May 29, 2025 Filed Jun 3, 2025 00:43 UTC | Life360, Inc. LIF · Entity 1972 | GrantCommon stock | 2,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-25-000134 · wk-form4_1748911393.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 961,315 F1 · kind: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2025, subject to the Reporting Person's continuous service through each vest date. F2 · balance_after: Includes 4,162 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 18:25 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 8,544 | $27.00 | $230,688.00 |
DisclosureSEC source: 0001581760-24-000061 · wk-form4_1718907937.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 1,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to the full exercise by the underwriters of a greenshoe option of the previously reported underwritten secondary offering that closed on June 7, 2024. F3 · balance_after: Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F4 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares sold and held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 18:25 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 362,580 | $27.00 | $9,789,660.00 |
DisclosureSEC source: 0001581760-24-000061 · wk-form4_1718907937.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 958,601 F1 · kind: The sales reported in this Form 4 were effected pursuant to the full exercise by the underwriters of a greenshoe option of the previously reported underwritten secondary offering that closed on June 7, 2024. F2 · balance_after: Includes 8,065 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. F3 · balance_after: Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 01:06 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 20,204 | $27.00 | $545,508.00 |
DisclosureSEC source: 0001415889-24-016450 · form4-06122024_010637.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 10,431 F1 · balance_after: Represents shares of the Issuer's common stock underlying 31,293 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 45,425 shares of the Issuer's common stock underlying 136,275 CDIs. The number of shares sold and held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 01:06 UTC | Life360, Inc. LIF · Entity 1972 | SaleCommon stock | 857,457 | $27.00 | $23,151,339.00 |
DisclosureSEC source: 0001415889-24-016450 · form4-06122024_010637.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,321,181 Read SEC document |
| May 29, 2024 Filed May 31, 2024 17:59 UTC | Life360, Inc. NONE · Entity 1972 | GrantCommon stock | 5,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-24-000042 · wk-form4_1717178380.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,178,638 F1 · shares: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2024, subject to the Reporting Person's continuous service through each vest date. F2 · balance_after: Includes 8,065 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:59 UTC | Life360, Inc. LIFX · Entity 1972 | GrantCommon stock | 9,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-23-000078 · wk-form4_1685656753.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,172,846 F1 · shares: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2023, subject to the Reporting Person's continuous service through each such date. F2 · balance_after: Includes 10,191 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.